DNA methylation characteristics associated with chemotherapy resistance in epithelial ovarian cancer
Objective: The high mortality rate of epithelial ovarian cancer (EOC) is often attributed to the frequent development of chemoresistance. DNA methylation is a predictive biomarker for chemoresistance. Methods: This study utilized DNA methylation profiles and relevant information from GEO and TCGA to...
Main Authors: | Changling Duan, Zhongxin Yan, Cailiang Wu, Xuexin Zhou, Wei Bao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024032432 |
Similar Items
-
OPCML Methylation and the Risk of Ovarian Cancer: A Meta and Bioinformatics Analysis
by: Yang Shao, et al.
Published: (2021-03-01) -
Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer
by: Xiangbin Xing, et al.
Published: (2017-04-01) -
A polygenic methylation prediction model associated with response to chemotherapy in epithelial ovarian cancer
by: Lanbo Zhao, et al.
Published: (2021-03-01) -
LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancer
by: Li-yuan Feng, et al.
Published: (2021-05-01) -
Gemcitabine–oxaliplatin (GEMOX) for epithelial ovarian cancer patients resistant to platinum-based chemotherapy
by: Mohamed Elshebeiny, et al.
Published: (2016-09-01)